Neuren Pharmaceutical's partner Acadia reports boosted sales of the Rett syndrome drug Daybue, but Neuren notes two-thirds of ...

People with a wheat or soy allergy could experience a "serious or life-threatening" reaction if they consume the product.

Becton, Dickinson and Company (NYSE:BDX) is one of the top stocks that Grok recommended. On July 31, Becton, Dickinson and ...

Technological innovation and personalized care are transforming Hims & Hers into a proactive health platform. Read why I ...

Orthofix Medical’s 2025 sell-off presents a value opportunity, says Rewey Asset Management. Learn why insiders are buying and ...

Baker Mayfield addressed the NFL’s 2025 smelling salts ban with sarcasm and hinted at a surprising new game day energy boost.

The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million ...

MAX BioPharma and Revilico Collaboration LOS ANGELES, CA / ACCESS Newswire / August 6, 2025 / Today MAX BioPharma, Inc. ( and Revilico, Inc. ( announced their collaboration in studying the mechanisms ...

U.S. health officials have issued warnings on two separate Boston Scientific heart devices recently linked to injuries and ...

Jazz Pharmaceuticals bet $1 billion on the commercial potential of a first-in-class oral imipridone for recurrent H3 K27M-mutant diffuse glioma.

Discover the truth about parasite cleanses trending on social media. Learn about parasitic infections, symptoms, FDA-approved ...

The company's revenue (GAAP) reached $21.2 million, up from $15.3 million in Q2 2024, outpacing the analyst consensus of $20.45 million (GAAP). Earnings per share (EPS, GAAP) were $(0.38), also better ...